23 results · 15ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

QUIES SAS

Manufacturer
🇫🇷 France·7 Basic UDI-DIs·9 Devices

Doculyse

Device
EU MDR · Eu Md Class 1 ·QUIES SAS·On the market

Anti Snoring Lozenges C

Device
EU MDD · Eu Md Class 1 ·QUIES SAS·On the market

Anti Snoring Lozenges HL

Device
EU MDD · Eu Md Class 1 ·QUIES SAS·On the market

Anti Snoring Oral Spray

Device
EU MDD · Eu Md Class 1 ·QUIES SAS·On the market

Anti Snoring Nasal Strips L

Device
EU MDR · Eu Md Class 1 ·QUIES SAS·On the market·3 countries

Anti Snoring Nasal Strips SM

Device
EU MDR · Eu Md Class 1 ·QUIES SAS·On the market

Anti Snoring Nasal Spray

Device
EU MDD · Eu Md Class 1 ·QUIES SAS·On the market

Docuspray

Device
EU MDR · Eu Md Class 1 ·QUIES SAS·On the market

Doculyse

Device
EU MDR · Eu Md Class 1 ·QUIES SAS·On the market·6 countries

ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL)

FDA 510(k)
FDA Class 2 ·Microbiology

ETEST Piperacillin/Tazobactam (P/T) (0.016/4-256/4 ug/mL)

FDA 510(k)
FDA Class 2 ·Microbiology

Anti Snoring Lozenges

Basic UDI-DI
EU MDD · Eu Md Class 1 ·QUIES SAS·1 device

Anti Snoring Lozenges

Basic UDI-DI
EU MDD · Eu Md Class 1 ·QUIES SAS·1 device

Anti Snoring Oral Spray

Basic UDI-DI
EU MDD · Eu Md Class 1 ·QUIES SAS·1 device

Anti Snoring Nasal Spray

Basic UDI-DI
EU MDD · Eu Md Class 1 ·QUIES SAS·1 device

Docuspray

Basic UDI-DI
EU MDR · Eu Md Class 1 ·QUIES SAS·1 device

Doculyse

Basic UDI-DI
EU MDR · Eu Md Class 1 ·QUIES SAS·2 devices

Anti Snoring Nasal Strips

Basic UDI-DI
EU MDR · Eu Md Class 1 ·QUIES SAS·2 devices

Etest¿ Piperacillin/tazobactam (4 ug/mL) PTc0.016-256-pack of 30 tests WW Etest¿ is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria.

FDA Enforcement
Class I ·Terminated·Biomerieux·December 30, 2015